To include your compound in the COVID-19 Resource Center, submit it here.
Cellectis sold its Cellectis AB subsidiary to Takara. The subsidiary is focused on applications of
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury